Dymista Allergen Chamber - Onset of Action Study
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3; Drug: Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 5; Drug: Treatment A (Dymista): Fixed drug combination of azelastine hy drochloride and fluticasone propionate nasal spray at Visit 5; Drug: Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 3 Sponsor: MEDA Pharma GmbH & Co. KG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
Allergic Rhinitis Combination Pharmacotherapy Efficacy Study
Condition: Allergic Rhinitis Interventions: Drug: Fluticasone Propionate; Drug: Azelastine hydrochloride and fluticasone propionate; Drug: Rupatadine Sponsor: St. Paul's Sinus Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials
